Free Newsletter
HRT doesn't protect women from heart disease
Investigators have identified a molecule that counteracts estrogen in the cardiovascular system as well as activating estrogen receptors in breast tissue, promoting the development of tumors. The scientific team at the University of Texas Southwestern Medical Center in Dallas say that a drug that inhibits 27HC could play a big role in promoting women's health. Their work has helped explain why the Women's Health Initiative astounded many observers several years ago when it revealed that hormone replacement therapy was linked to a higher rate of heart disease. It turns out that 27HC is produced while the body processes cholesterol.
- see the release on the findings
- read the article from The Wall Street Journal (sub. req.)
ALSO: University of Iowa researchers have discovered a gene that plays a linchpin role in the ability of breast cancer cells to respond to estrogen. The finding may lead to improved therapies for hormone-responsive breast cancers and may explain differences in the effectiveness of current treatments. Release
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




